SANGAMO THERAPEUTICS, INC Logo

SANGAMO THERAPEUTICS, INC

A clinical-stage genomic medicine company developing therapies for severe diseases.

SGMO | US

Overview

Corporate Details

ISIN(s):
US8006771062
LEI:
Country:
United States of America
Address:
501 CANAL BLVD., 94084 RICHMOND

Description

Sangamo Therapeutics, Inc. is a clinical-stage genomic medicine company focused on translating groundbreaking science into medicines for patients with severe diseases. The company utilizes its proprietary zinc finger (ZFN) technology platform to develop a pipeline of genomic therapies. Its research and development efforts are concentrated on creating potential cures and treatments for a range of conditions, including neurological disorders, autoimmune diseases, and oncology. Sangamo aims to address the underlying genetic causes of diseases where current medical options primarily offer symptom management.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-12-30 22:23
8-K
English 73.0 KB
2024-12-10 03:27
8-K
English 3.1 MB
2024-11-26 22:10 English 8.3 KB
2024-11-26 22:09 English 8.3 KB
2024-11-26 22:08 English 8.4 KB
2024-11-26 22:08 English 8.3 KB
2024-11-26 22:07 English 8.3 KB
2024-11-20 06:15 English 4.8 KB
2024-11-19 00:10 English 7.4 KB
2024-11-18 22:36 English 57.7 KB
2024-11-12 23:25
S-8
English 31.7 KB
2024-11-12 23:24
S-3
English 545.2 KB
2024-11-12 22:53 English 7.9 KB
2024-11-12 22:02
10-Q
English 2.6 MB
2024-11-12 22:01
8-K
English 206.0 KB

Automate Your Workflow. Get a real-time feed of all SANGAMO THERAPEUTICS, INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SANGAMO THERAPEUTICS, INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SANGAMO THERAPEUTICS, INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Adaptive Biotechnologies Corp Logo
Decodes the adaptive immune system to develop products for diagnosing and treating disease.
United States of America
ADPT
Adeia Inc. Logo
R&D company that licenses IP for the media, entertainment, and semiconductor industries.
United States of America
ADEA
Aditxt, Inc. Logo
Acquires, develops, and deploys health technologies to address major health challenges.
United States of America
ADTX
Advanced Biomed Inc. Logo
Develops microfluidic biochip diagnostic systems for precision oncology.
United States of America
ADVB
AIM ImmunoTech Inc. Logo
Immuno-pharma company developing therapeutics for oncology, immune, and viral diseases.
United States of America
AIM
Ainos, Inc. Logo
Develops AI-driven diagnostics, immune therapeutics, and telehealth POCT devices.
United States of America
AIMD
Akero Therapeutics, Inc. Logo
Clinical-stage company developing treatments for serious metabolic diseases like MASH.
United States of America
AKRO
Aladdin Healthcare Technologies SE Logo
Develops AI-powered tools for drug discovery and diagnostics for age-related conditions.
Germany
NMI
Alaunos Therapeutics, Inc. Logo
Clinical-stage immuno-oncology company developing TCR-T cell therapies for solid tumors.
United States of America
TCRT
Aligos Therapeutics, Inc. Logo
A clinical-stage biopharmaceutical company developing therapeutics for liver and viral diseases.
United States of America
ALGS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.